CCL2 and inflammatory bowel disease: IP-10, a selective attractant of activated T-lymphocytes together with MCP-1 and MCP-3, chemokines that act on monocytes, activated T-lymphocytes, eosinophils, and basophils, are described as powerful players in the disease severity of patients with IBD.